000105.KS Live signals | Maximize Profits with Getagraph.com

Live Chart Being Loaded With Signals

Commentary (17 May 2024 @ 02:30):

Yuhan Corporation, a pharmaceutical company, engages in the research, development, and production of active pharmaceutical products and intermediates in South Korea and internationally...

Stats
Today's Volume	12 131.00
Average Volume	2 493.00
Market Cap	5 378.71B
EPS	KRW0 ( 2024-05-09 )
Next earnings date	( KRW0 ) 2024-07-26
Last Dividend	KRW0 ( N/A )
Next Dividend	KRW0 ( N/A )
P/E	0
ATR14	KRW48.74 (0.08%)

Volume Correlation

Long: -0.05 (neutral)

Short: -0.65 (moderate negative)

Signal:(71.663) Neutral

Yuhan Corporation Correlation

10 Most Positive Correlations

10 Most Negative Correlations

Did You Know?

Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).

Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.

Yuhan Corporation Correlation - Currency/Commodity

-0.81
( strong negative )

-0.85
( strong negative )

0.01
( neutral )

0.06
( neutral )

0.64
( weak )

0.28
( neutral )

Yuhan Corporation Financials

Annual	2023
Revenue:	KRW1 858.98B
Gross Profit:	KRW595.83B (32.05 %)
EPS:	KRW1 815.36

FY	2023
Revenue:	KRW1 858.98B
Gross Profit:	KRW595.83B (32.05 %)
EPS:	KRW1 815.36

FY	2022
Revenue:	KRW1 775.85B
Gross Profit:	KRW518.20B (29.18 %)
EPS:	KRW1 328.75

FY	2021
Revenue:	KRW1 687.81B
Gross Profit:	KRW524.65B (31.08 %)
EPS:	KRW7 444.15

Financial Reports:

No articles found.

Yuhan Corporation Options Data

Calls

Contract Name	Last Trade Date (EDT)	Strike	Last Price	Bid	Ask	Change	% Change	Volume	Open Interest	Implied Volatility	Strike Date
No data available

Puts

Contract Name	Last Trade Date (EDT)	Strike	Last Price	Bid	Ask	Change	% Change	Volume	Open Interest	Implied Volatility	Strike Date
No data available

Yuhan Corporation

Yuhan Corporation, a pharmaceutical company, engages in the research, development, and production of active pharmaceutical products and intermediates in South Korea and internationally. It offers antivirals, antibiotics, antihistamines, antidiabetics, beta-lactamase inhibitors, CNS intermediates, and PEGylated compounds; Revanex, an acid pump antagonist for the treatment of peptic ulcers and gastritis-related mucosal injury; ETC products in the areas of cardiovascular, alimentary, genito-urinary, metabolic, respiratory and allergy, and neuro systems; anti-infective, anti-cancer, and hormone and other products; and analgesics, anti-rheumatics, and anesthetics. It also offers OTC products, including vitamins and minerals, hepatopathy drugs and tonics, respiratory system drugs, alimentary system drugs, dermatology and analgesics drugs, and others; and household and healthcare products, such as bleaches, detergents, pesticides, and oral care products. In addition, the company engages in dental business and offers implants, dental equipment/consumable, and dental care products. Additionally, the company manufactures and sells medical supplies for livestock, aquatic animals, and household pets. Further, it provides contract manufacturing services. Yuhan Corporation was founded in 1926 and is headquartered in Seoul, South Korea.